Long-acting Reversible Contraceptive (LARC)

Showing 1-8 of 43 results

Clinical scenario: Contraception and autoimmune conditions

What providers need to know about safety and contraceptive decision-making for patients with autoimmune conditions

Clinical scenario: Placing an IUD after unprotected sex

What providers need to know about placing a levonorgestrel intrauterine device (LNG-IUD) after unprotected sex

More than just lidocaine: Person-centered pain strategies for IUD placement

Review of evidence-based, person-centered strategies for improving patient comfort during IUD placements, from paracervical blocks to non-medication supports

Research roundup: February 2025 edition

Double dosing UPA for EC not needed for BMI > 30, postpartum implant placement and milk supply, mifepristone to increase efficacy of medication management of EPL.

Clinical scenario: How long are IUDs and implants effective?

What providers need to know when talking with patients about evidence-based recommendations for IUD and implant duration of use and effectiveness

Research roundup: December 2024 edition

Clinical trial data on a new IUD, clinical guidance on self-managed abortion, the impact of the ACA on reproductive health, and CDC’s abortion surveillance data.

Research roundup: October 2024 edition

LNG-IUD and the risk of gynecologic and breast cancers, contraception and body weight, and preferred ways to get hormonal birth control.

Research roundup: September 2024 edition

Ongoing support for forgoing Rh testing in early pregnancy, medication abortion before six weeks, provider bias on contraceptive counseling adolescents, and local anesthesia before procedural abortion.
  • Previous
  • 1(current)
  • 2
  • 3
  • 4
  • 5
  • Next